Grant PJ - Search Results

1

Coagulation and atherothrombotic disease.

Ajjan R, Grant PJ. Ajjan R, et al. Among authors: grant pj. Atherosclerosis. 2006 Jun;186(2):240-59. doi: 10.1016/j.atherosclerosis.2005.10.042. Epub 2005 Dec 15. Atherosclerosis. 2006. PMID: 16343508 Review.

2

Role of clotting factors and fibrin structure in predisposition to atherothrombotic disease.

Ajjan RA, Grant PJ. Ajjan RA, et al. Among authors: grant pj. Expert Rev Cardiovasc Ther. 2005 Nov;3(6):1047-59. doi: 10.1586/14779072.3.6.1047. Expert Rev Cardiovasc Ther. 2005. PMID: 16292996 Review.

3

Complement C3 and C-reactive protein levels in patients with stable coronary artery disease.

Ajjan R, Grant PJ, Futers TS, Brown JM, Cymbalista CM, Boothby M, Carter AM. Ajjan R, et al. Among authors: grant pj. Thromb Haemost. 2005 Nov;94(5):1048-53. doi: 10.1160/TH05-06-0384. Thromb Haemost. 2005. PMID: 16363249

4

Cardiovascular disease prevention in patients with type 2 diabetes: The role of oral anti-diabetic agents.

Ajjan RA, Grant PJ. Ajjan RA, et al. Among authors: grant pj. Diab Vasc Dis Res. 2006 Dec;3(3):147-58. doi: 10.3132/dvdr.2006.023. Diab Vasc Dis Res. 2006. PMID: 17160909 Free article. Review.

5

Common variation in the C-terminal region of the fibrinogen beta-chain: effects on fibrin structure, fibrinolysis and clot rigidity.

Ajjan R, Lim BC, Standeven KF, Harrand R, Dolling S, Phoenix F, Greaves R, Abou-Saleh RH, Connell S, Smith DA, Weisel JW, Grant PJ, Ariëns RA. Ajjan R, et al. Among authors: grant pj. Blood. 2008 Jan 15;111(2):643-50. doi: 10.1182/blood-2007-05-091231. Epub 2007 Oct 9. Blood. 2008. PMID: 17925485 Free article.

6

The cardiovascular safety of rosiglitazone.

Ajjan RA, Grant PJ. Ajjan RA, et al. Among authors: grant pj. Expert Opin Drug Saf. 2008 Jul;7(4):367-76. doi: 10.1517/14740338.7.4.367. Expert Opin Drug Saf. 2008. PMID: 18613801 Review.

7

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten RA, Atzler D, Grant PJ, Böger RH. Schulze F, et al. Among authors: grant pj. Atherosclerosis. 2010 Feb;208(2):518-23. doi: 10.1016/j.atherosclerosis.2009.06.039. Epub 2009 Jul 23. Atherosclerosis. 2010. PMID: 19700158

8

Gender-specific alterations in fibrin structure function in type 2 diabetes: associations with cardiometabolic and vascular markers.

Alzahrani SH, Hess K, Price JF, Strachan M, Baxter PD, Cubbon R, Phoenix F, Gamlen T, Ariëns RA, Grant PJ, Ajjan RA. Alzahrani SH, et al. Among authors: grant pj. J Clin Endocrinol Metab. 2012 Dec;97(12):E2282-7. doi: 10.1210/jc.2012-2128. Epub 2012 Sep 20. J Clin Endocrinol Metab. 2012. PMID: 22996148

9

Diabetes is associated with posttranslational modifications in plasminogen resulting in reduced plasmin generation and enzyme-specific activity.

Ajjan RA, Gamlen T, Standeven KF, Mughal S, Hess K, Smith KA, Dunn EJ, Anwar MM, Rabbani N, Thornalley PJ, Philippou H, Grant PJ. Ajjan RA, et al. Among authors: grant pj. Blood. 2013 Jul 4;122(1):134-42. doi: 10.1182/blood-2013-04-494641. Epub 2013 May 22. Blood. 2013. PMID: 23699598 Free article.

10

BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes.

Greenhalgh KA, Strachan MW, Alzahrani S, Baxter PD, Standeven KF, Storey RF, Ariens RA, Grant PJ, Price JF, Ajjan RA. Greenhalgh KA, et al. Among authors: grant pj. Thromb Haemost. 2017 Jan 26;117(2):295-302. doi: 10.1160/TH16-07-0554. Epub 2016 Dec 8. Thromb Haemost. 2017. PMID: 27929198 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters